Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have received an average recommendation of "Buy" from the thirteen research firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $20.67.

Several analysts have recently weighed in on ARDT shares. Stephens reissued an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a report on Tuesday, May 20th. Guggenheim boosted their target price on Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, May 9th. Mizuho reduced their target price on Ardent Health from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $21.00 target price on shares of Ardent Health in a report on Thursday, May 15th.

Hedge Funds Weigh In On Ardent Health

Large investors have recently modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Ardent Health during the fourth quarter worth about $27,000. US Bancorp DE purchased a new stake in Ardent Health during the fourth quarter worth about $31,000. Morse Asset Management Inc purchased a new stake in Ardent Health during the first quarter worth about $36,000. New York State Common Retirement Fund purchased a new position in Ardent Health in the 4th quarter valued at approximately $48,000. Finally, Deutsche Bank AG increased its stake in Ardent Health by 1,251.9% in the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after purchasing an additional 2,654 shares in the last quarter.

Ardent Health Stock Down 0.4%

Shares of ARDT traded down $0.05 during midday trading on Thursday, reaching $13.37. The stock had a trading volume of 104,061 shares, compared to its average volume of 380,955. Ardent Health has a 1-year low of $11.31 and a 1-year high of $20.72. The company's fifty day simple moving average is $13.88 and its two-hundred day simple moving average is $14.14. The company has a market cap of $1.91 billion and a price-to-earnings ratio of 8.20. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.12 and a quick ratio of 1.98.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to analysts' expectations of $1.50 billion. Ardent Health had a return on equity of 16.07% and a net margin of 3.73%. Equities research analysts expect that Ardent Health will post 1.23 earnings per share for the current year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.